Medicaid Directors Urge Federal Policy Changes To Fight High-Cost Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
The National Association of Medicaid Directors asks Congress to enact policies lessening the impact of Sovaldi and other high-cost specialty medications on state budgets. NAMD's options include direct price controls and higher mandatory rebates for certain drugs.